Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Cepheid Outlines Assay Improvements, Xpert Cartridge Partnering Program at ECCMID

Cepheid Outlines Assay Improvements, Xpert Cartridge Partnering Program at ECCMID

Apr 15, 2019
|
Ben Butkus
Premium

AMSTERDAM (GenomeWeb) – A Cepheid executive today provided an update on upcoming improvements to various Xpert real-time PCR-based molecular assays and outlined a new partnering program that aims to validate and commercialize third-party assays on the company's Xpert microfluidic test cartridges.

In addition, an early user of a new Xpert-based Mycoplasma genitalium and antibiotic resistance test from SpeeDx, Cepheid's first cartridge partner, shared initial validation data on the assay.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Funds Sought for Vaccine Distribution

The Washington Post reports that US states and territories are seeking more funding for the distribution of SARS-CoV-2 vaccines.

Virus Variant From Spain Now Across UK

The strain now accounts for about 80 percent of cases in Wales and Scotland, and about half of cases in England, the Guardian reports.

Unexpected Loss

A new study suggests that using CRISPR to edit human embryonic DNA can lead to the loss of whole chromosomes, as the Associated Press reports.

Science Papers on Long Human-Canine Relationship, Population History of Early East Asians, More

In Science this week: ancient dog genomes highlight long ties with humans, genomic analysis of 40,000-year-old early East Asian individual, and more.

What's Popular?

In Business News

  1. Illumina Q3 Revenues Down 12 Percent

  2. Qiagen, Phase Genomics Ink US Licensing Agreement for Hi-C Sequencing Technloogy

  3. Bio-Rad Q3 Revenues Jump 15 Percent

  4. Opko Health Q3 Revenues Up 87 Percent

  5. Biocartis, Exact Sciences Terminate Oncotype DX Agreement

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.